Analysts
Scores, price targets and rating changes published by the firms we track. Informational, not advice.
Price target forecast
The average analyst target through the past year, and where analysts see the price a year from now.
Nov 6, 202610 analyst targets · 90 days
- Share price
- $8.04
- Average 1Y price target
- $13.56+68.66%
- Agreement
- Low
Analysts agreement range is spread more than 30% from the average
Share priceAverage analyst target (90-day window), shaded 10th–90th percentile12-month range from the lowest to the highest current target, dashed to the average
Rating scores
Each factor is scored 1 (weak) to 5 (strong).
- Overall1
- DCF1
- Return on equity1
- Return on assets1
- Debt / equity4
- P/E1
- P/B1
Average price target
Mean of the targets analysts published in each window.
| Window | Targets | Average |
|---|---|---|
| Last month | 2 | $13.00 |
| Last quarter | 10 | $13.90 |
| Last year | 15 | $11.33 |
| All time | 35 | $14.14 |
Recent rating changes
The latest 40 changes by research firm, newest first.
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 6, 2026 | Citizens | maintain | Market Outperform | Market Outperform |
| Nov 6, 2026 | Barclays | maintain | Overweight | Overweight |
| Nov 3, 2026 | UBS | maintain | Neutral | Neutral |
| Oct 13, 2026 | Barclays | maintain | Overweight | Overweight |
| Oct 8, 2026 | Baird | maintain | Neutral | Neutral |
| Sep 30, 2026 | Wells Fargo | maintain | Overweight | Overweight |
| Sep 29, 2026 | HC Wainwright & Co. | maintain | Buy | Buy |
| Sep 17, 2026 | Barclays | maintain | Overweight | Overweight |
| Aug 25, 2026 | TD Cowen | maintain | Buy | Buy |
| Aug 20, 2026 | UBS | maintain | Neutral | Neutral |
| Aug 18, 2026 | Mizuho | maintain | Outperform | Outperform |
| Aug 7, 2026 | Citizens | maintain | Market Outperform | Market Outperform |
| Aug 7, 2026 | Barclays | maintain | Overweight | Overweight |
| May 7, 2026 | Chardan Capital | maintain | Buy | Buy |
| Apr 10, 2026 | Chardan Capital | maintain | Buy | Buy |
| Mar 5, 2026 | UBS | maintain | Neutral | Neutral |
| Mar 3, 2026 | Citizens | upgrade | Market Perform | Market Outperform |
| Feb 25, 2026 | Citizens | upgrade | Market Perform | Market Outperform |
| Feb 25, 2026 | Barclays | maintain | Overweight | Overweight |
| Dec 17, 2025 | Barclays | maintain | Overweight | Overweight |
| Nov 24, 2025 | Barclays | maintain | Overweight | Overweight |
| Nov 6, 2025 | Chardan Capital | maintain | Buy | Buy |
| Oct 29, 2025 | HC Wainwright & Co. | maintain | Buy | Buy |
| Aug 19, 2025 | HC Wainwright & Co. | maintain | Buy | Buy |
| Aug 8, 2025 | Wells Fargo | maintain | Overweight | Overweight |
| Aug 8, 2025 | Chardan Capital | maintain | Buy | Buy |
| Jul 23, 2025 | Chardan Capital | maintain | Buy | Buy |
| May 16, 2025 | UBS | downgrade | Buy | Neutral |
| May 12, 2025 | Mizuho | maintain | Outperform | Outperform |
| May 12, 2025 | Goldman Sachs | maintain | Buy | Buy |
| May 12, 2025 | Barclays | maintain | Overweight | Overweight |
| May 9, 2025 | JMP Securities | downgrade | Market Outperform | Market Perform |
| May 9, 2025 | HC Wainwright & Co. | maintain | Buy | Buy |
| May 9, 2025 | Chardan Capital | maintain | Buy | Buy |
| Apr 17, 2025 | Goldman Sachs | maintain | Buy | Buy |
| Apr 14, 2025 | Barclays | maintain | Overweight | Overweight |
| Mar 3, 2025 | Truist Securities | maintain | Buy | Buy |
| Mar 3, 2025 | Goldman Sachs | maintain | Buy | Buy |
| Mar 3, 2025 | Chardan Capital | maintain | Buy | Buy |
| Feb 28, 2025 | Piper Sandler | maintain | Neutral | Neutral |